Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Olivia Newton John Cancer Research Institute
Scientific Title
A phase I/II open-label trial of intravenous CAVATAKTM in combination with Pembrolizumab for the treatment of patients with advanced NSCLC